QR-kod

Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C Infections

Background. Transplanting hepatitis C viremic donor organs into hepatitis C virus (HCV)-negative recipients is becoming increasingly common; however, practices for posttransplant direct-acting antiviral (DAA) treatment vary widely. Protracted insurance authorization processes for DAA therapy often l...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphov: Zoe A. Stewart, MD, PhD, Jeffrey Stern, MD, Nicole M. Ali, MD, Harmit S. Kalia, DO, Karen Khalil, PharmD, Srijana Jonchhe, PharmD, Elaina P. Weldon, MSN, Rebecca A. Dieter, PharmD, Tyler C. Lewis, PharmD, Nur Funches, BS, Sudara Crosby, AA, Monique Seow, HSD, Jonathan C. Berger, MD, Nabil N. Dagher, MD, Bruce E. Gelb, MD, Anthony C. Watkins, MD, Nader Moazami, MD, Deane E. Smith, MD, Zachary N. Kon, MD, Stephanie H. Chang, MD, Alex Reyentovich, MD, Luis F. Angel, MD, Robert A. Montgomery, MD, PhD, Bonnie E. Lonze, MD, PhD
Materialtyp: Artigo
Språk:Inglês
Utgiven: Wolters Kluwer 2021-10-01
Serie:Transplantation Direct
Länkar:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001222
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!